Suche
Filter by content type
Filter by content year
Filter by category
BioNTech and Fosun Pharma receive approval to commence COVID-19 Vaccine Candidate BNT162b2 trial in China
November 16, 2020 - … BioNTech and Fosun Pharma receive approval to commence COVID-19 Vaccine Candidate BNT162b2 trial in China … BioNTech and Fosun Pharma receive approval to commence COVID-19 Vaccine Candidate BNT162b2 trial in China BioNTech and Fosun Pharma receive approval to commence COVID-19 Vaccine …
BioNTech and Fosun Pharma Announce the Start of a Phase 2 Clinical Trial of Lead mRNA COVID-19 Vaccine BNT162b2 in China
November 25, 2020 - … BioNTech and Fosun Pharma Announce the Start of a Phase 2 Clinical Trial … mRNA COVID-19 Vaccine BNT162b2 in China … BioNTech and Fosun Pharma Announce the Start of a Phase 2 Clinical Trial … Lead mRNA COVID-19 Vaccine BNT162b2 in China BioNTech and Fosun Pharma Announce the Start of a Phase 2 Clinical Trial …
BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based COVID-19 Vaccine Candidate in China
August 5, 2020 - … BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based … COVID-19 Vaccine Candidate in China … BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based … COVID-19 Vaccine Candidate in China BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based …
BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany
April 29, 2020 - … facilities in Europe. BioNTech is collaborating with Fosun Pharma to develop BNT162 in China, where the companies … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … between BioNTech and Pfizer, and BioNTech and Fosun Pharma, to develop a potential COVID-19 vaccine; and …
BioNTech and Pfizer announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates
April 22, 2020 - … facilities in Europe. BioNTech is also collaborating with Fosun Pharma to develop BNT162 in China, where the companies … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … between BioNTech and Pfizer, and BioNTech and Fosun Pharma, to develop a potential COVID-19 vaccine; the …
Pfizer and BioNTech Dose First Participants in the U.S. as Part of Global COVID-19 mRNA Vaccine Development Program
Mai 5, 2020 - … (excluding China, where BioNTech has a collaboration with Fosun Pharma for BNT162 for both clinical development and … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … between BioNTech and Pfizer, and BioNTech and Fosun Pharma, to develop a potential COVID-19 vaccine; and …
Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data
Juli 20, 2020 - … (excluding China, where BioNTech has a collaboration with Fosun Pharma for BNT162 for both clinical development and … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … between BioNTech and Pfizer, and BioNTech and Fosun Pharma, to develop a potential COVID-19 vaccine; the …
Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
Juli 1, 2020 - … (excluding China, where BioNTech has a collaboration with Fosun Pharma for BNT162 for both clinical development and … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … between BioNTech and Pfizer, and BioNTech and Fosun Pharma, to develop a potential COVID-19 vaccine; the …
BioNTech und Fosun Pharma beginnen klinische Studie mit mRNA-basiertem COVID-19-Impfstoffkandidaten in China
August 5, 2020 - … BioNTech und Fosun Pharma beginnen klinische Studie mit mRNA-basiertem … COVID-19-Impfstoffkandidaten in China … BioNTech und Fosun Pharma beginnen klinische Studie mit mRNA-basiertem … COVID-19-Impfstoffkandidaten in China BioNTech und Fosun Pharma beginnen klinische Studie mit mRNA-basiertem …
Pfizer and BioNTech Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2
Juli 13, 2020 - … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma, and Pfizer. For more information, please visit … between BioNTech and Pfizer, and BioNTech and Fosun Pharma, to develop a potential COVID-19 vaccine; and … Health, Genentech, a member of the Roche Group, Genevant, Fosun Pharma, and Pfizer. For more information, please visit …